Products
products details
Home > Products >
GLP-1 (1-37) Human Hormone Peptide Catalog Number KS032002 CAS 87805-34-3

GLP-1 (1-37) Human Hormone Peptide Catalog Number KS032002 CAS 87805-34-3

Product Details:
Catalog Number:
KS032002
Product Name:
GLP-1 (1-37) (human)
Sequence:
HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG-OH (trifluoroacetate Salt)
CAS NO.:
87805-34-3
Price/1mg:
$304
Purity:
≥95% (HPLC)
Molecular Formula:
C186H275N51O59
Molecular Weight:
4169.6
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
High Light: 

GLP-1 Hormone Peptide

,

Hormone Peptide 87805-34-3

,

Hormone glp 1 peptide

Product Description

GLP-1 (1-37) (human),Catalog Number: KS032002,CAS NO.: 87805-34-3

 

GLP, synthesized by posttranslational processing of proglucagon in the intestine and pancreas, plays an important role in metabolic homeostasis. It is capable of converting intestinal epithelial cells into insulin-producing cells, thus serving as a new putative therapeutic compound for the treatment of diabetes mellitus.

Products
products details
Home > Products >
GLP-1 (1-37) Human Hormone Peptide Catalog Number KS032002 CAS 87805-34-3

GLP-1 (1-37) Human Hormone Peptide Catalog Number KS032002 CAS 87805-34-3

Product Details:
Catalog Number:
KS032002
Product Name:
GLP-1 (1-37) (human)
Sequence:
HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG-OH (trifluoroacetate Salt)
CAS NO.:
87805-34-3
Price/1mg:
$304
Purity:
≥95% (HPLC)
Molecular Formula:
C186H275N51O59
Molecular Weight:
4169.6
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
Details Link:
Https://shopping.ks-vpeptide.com/sale-470527-glp-1-1-37-human-hormone-peptide-catalog-number-ks032002-cas-87805-34-3.htm
High Light: 

GLP-1 Hormone Peptide

,

Hormone Peptide 87805-34-3

,

Hormone glp 1 peptide

Product Description

GLP-1 (1-37) (human),Catalog Number: KS032002,CAS NO.: 87805-34-3

 

GLP, synthesized by posttranslational processing of proglucagon in the intestine and pancreas, plays an important role in metabolic homeostasis. It is capable of converting intestinal epithelial cells into insulin-producing cells, thus serving as a new putative therapeutic compound for the treatment of diabetes mellitus.